XML 53 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (1,250,539) $ (1,377,026)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation 32,049 29,905
Amortization of intangible assets 10,204 10,205
Gain on derivative liabilities (42,228) (117,153)
Share-based compensation 258,297 $ 170,282
Amortization on note payable discount $ 20,000
Other $ 6
Change in assets and liabilities:    
Accounts receivable $ (1,540,075) (347,549)
Due from factor 76,657 (19,259)
Inventory (138,895) (2,649)
Prepaid expenses and other 198,841 (7,104)
Accounts payable 960,673 (83,634)
Accrued liabilities (55,824) $ 144,216
Due to factor 533,422
Deferred revenue (36,418) $ (97,057)
Net cash used for operating activities (973,836) (1,696,817)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (2,078) (9,353)
Net cash used for investing activities $ (2,078) (9,353)
CASH FLOW FROM FINANCING ACTIVITIES:    
Repurchase of outstanding warrants $ (150,000)
Stock issued to directors $ 13,000
Proceeds from issuance of Note Payable 250,000
Costs to issue common stock (58,486)
Net cash provided by (used for) financing activities 204,514 $ (150,000)
NET DECREASE IN CASH AND CASH EQUIVALENTS (771,400) (1,856,170)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 843,632 2,023,349
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 72,232 $ 167,179
Cash paid for:    
Interest
Noncash Investing and Financing Activities:    
Issuance of warrants for financing raise $ 92,199